GE Healthcare: India Edison Accelerator Cohort 3 Demo Day

Chaith Kondragunta, CEO of AIRA MATRIX speaking at GE Healthcare India Edison Accelerator Cohort 3 Demo Day

AIRAMATRIX has received the ISO 9001:2015 certification

Our management system has been registered as conforming to the requirements of ISO 9001:2015

The management system is applicable to - The Design and Development, Installation, Distribution and Servicing of Software Solutions used in Life Sciences.

Publication in Scientific Reports (Nature Portfolio)

Our paper "A deep learning system for prostate cancer diagnosis and grading in whole slide images of core needle biopsies" has been published in the March issue of Scientific Reports (Nature Portfolio).

The paper describes our system for the automated triaging and grading of whole slide images from biopsies of prostate carcinoma patients. Our Deep Learning based system, when used as an assistive tool for core needle biopsy (CNB) reviews, improves the consistency and accuracy of grading and can lead to better patient outcomes.

Read More

AIRA Matrix collaborates with MPUH and GIC to develop AI based solutions for prostate cancer care

AIRA Matrix has announced a collaboration with Muljibhai Patel Urological Hospital, Nadiad (MPUH) and Gujarat Imaging Centre, Ahmedabad (GIC). The collaboration will enable development of Artificial Intelligence based solutions that provide insights from radiology and histopathology data for accurate risk stratification and therapy institution in prostate cancer.

Read More

Article accepted for presentation at the Medical Imaging with Deep Learning (MIDL) 2022.

An article from the Advanced Technology Group (ATG) at AIRAMATRIX have been accepted for presentation at the Medical Imaging with Deep Learning (MIDL) 2022.

Conference Website

AIRAMATRIX has received 12th Aegis Graham Bell Award under the Innovation in Life Science category

AIRA MATRIX is excited to announce that we are the proud recipient of the 12th edition of the Aegis Graham Bell Award under the Innovation in Life Science category. This award is supported by the Ministry of Electronics and Information Technology, Government of India, Skill India and National Informatics Centre. The award is for our "Accelerator for Preclinical Drug Development" which seeks to reduce testing on animals and helps quickly bring safe, efficacious drugs to the market.

Read More

Two articles have been accepted for presentation at the IEEE International Symposium on Biomedical Imaging (ISBI) 2022.

Two articles from the Advanced Technology Group (ATG) at AIRAMATRIX have been accepted for presentation at the IEEE International Symposium on Biomedical Imaging (ISBI) 2022.

Conference Website

Biomedical Research Across the Globe

Chaith Kondragunta, CEO of AIRA MATRIX, details our AI-based solutions that can positively impact Prostate Cancer outcomes in the latest January 2022 edition of Open Access Government.

Read More

AI-based solutions for pharma industry

AI-based solutions for pharma expedites go-to-market for drugs & vaccines: Chaith Kondragunta

Read More

Intelligent Health AI

Chaith Kondragunta, CEO of AIRA MATRIX, will speak about the usage of deep learning applications in pathology at Intelligent Health AI, 2021.

Read More

AI Transforming Indian Healthcare Industry

Nitisha from BISinfotech catch-up with Chaith Kondragunta, CEO, AIRA Matrix and other startups CEO's in healthcare space. Read More

AIRA MATRIX selected in the third cohort of the GE Healthcare India Edison Accelerator Program

AIRA MATRIX is proud to be selected in the third cohort of the GE Healthcare India Edison Accelerator Program. The Edison Accelerator enables companies to collaborate with experts from GE Healthcare to provide solutions that complement and integrate with GE’s product ecosystem.

Team AIRA MATRIX is excited to work with GE Healthcare on our solutions for Prostate cancer diagnostics, prognostics, and prediction.

Read More

Application Of AI In Speeding Up Drug Discovery & Development

AIRA MATRIX CEO Chaith Kondragunta discusses how AI implementations help speed up drug discovery and development in the latest issue of BW Healthcare World.

Read More

Chaith Kondragunta, CEO, AIRA MATRIX, speaks with Pharmabiz.com

AIRA MATRIX CEO, Chaith Kondragunta shares key insights on how Deep learning-based solutions can significantly change outcomes of cancer therapy.

Read More


TRANSFIN Podcasts: Gearing Up for an AI Future with Chaith Kondragunta of AIRA Matrix

Chaith Kondragunta, CEO, AIRA MATRIX, speaks with Anaytics Insight

AIRA MATRIX CEO, Chaith Kondragunta shares key insights on how our Deep Learning-based applications improve workflow efficiency and enable informed decision-making in the healthcare and pharma industries.

Read More

ARVO Imaging in the Eye Conference

AIRA MATRIX is happy to share that our submissions, “LEAP: LEsion-Aware Prediction of diabetic macular edema grades from color fundus images using deep learning”, and “Deep Learning-Based Ocular Disease Classification using Retinal Fundus Images” have been accepted for presentation at the 2021 ARVO IMAGING IN THE EYE conference.

The first paper will shed light on how our Deep Learning-based LEsion-Aware Prediction (LEAP) model effectively performs automatic detection and grading of Diabetic Macular Edema (DME). The model captures the interclass variability across DME grading, which can be highly impactful for screening programs worldwide.

The second paper will share key insights on how our Deep Learning algorithms with an ensemble of CNN models are capable of detecting and diagnosing diabetic retinopathy (DR), glaucoma, age-related macular degeneration (AMD), and other pathologies.

Read More

AIRA MATRIX and Pharmaseed announces collaboration

AIRAMatrix Pvt. Ltd. (“AIRA Matrix”), the premier provider of Artificial Intelligence (AI) products and services for the Life Sciences industries and Pharmaseed Ltd (“Pharmaseed”), Israel’s largest GLP-certified pre-clinical CRO specializing in translational and regenerative studies announced a strategic collaboration for developing AI applications for quantification of histological parameters derived from in-vivo disease models in animal studies.

Read More

Pathology AI Algorithms Deployed on Augmented Reality Microscope in Preclinical Study

Life sciences Artificial Intelligence products and services company, AIRA Matrix (“AIRA Matrix”), and microscope-based digital pathology platform Augmentiqs (“Augmentiqs”), announced the world’s first pre-clinical deployment of deep-learning algorithms in an augmented reality microscope.

Read More

AIRA Matrix announces webinar series on AI applications in Reproductive Toxicology

AIRA Matrix announces a webinar series on AI applications in Reproductive Toxicology. The first in the series, “Application of Artificial Intelligence for Spermatogenic Staging Assessment in Rodents” will be presented on Feb 11, 2021, in association with Dr. Dianne Creasy (Ph.D., DipRCPath (Tox), FRCPath). Dr. Creasy is a leading toxicologic pathologist and an expert in reproductive toxicology reporting.

Read More

AIRA MATRIX Invites You to a Luncheon Session: “Demystifying Deep Learning for Pathologists” at the 17th European Congress of Toxicologic Pathology

AIRA MATRIX is pleased to announce that it will be hosting a session titled, “Demystifying Deep Learning for Pathologists” on September 18th, 2019 at the 17th European Congress of Toxicologic Pathology organized by European Society of Toxicologic Pathology (ESTP).

Read More

AIRA Matrix CEO Chaith Kondragunta to deliver speech at Intelligent Health Inspired Online Summit

AIRA Matrix CEO, Chaith Kondragunta will be speaking at Intelligent Health Inspired, the world’s largest online summit dedicated to AI in medicine. The session titled, “AI Applications for Screening and Early Disease Detection in Pathology” is a part of the AI Innovation series.

Read More

Webinar | Application of Artificial Intelligence in Scoring Rodent Cardiomyopathy

Progressive cardiomyopathy (PCM) is a common background change seen in rodent toxicology. We invite you to participate and discuss deep learning applications for progressive cardiomyopathy (PCM) scoring in rodents.

Read More

AIRA Matrix Wins Second Place in the Global Gleason 2019 Challenge at MICCAI2019

AIRA Matrix wins second place in the global Gleason 2019 Challenge at MICCAI2019. The challenge involved automating the Gleason score, a highly reliable grading method for classifying the histologic characteristics of Prostate cancer. Our proposed deep learning algorithm will help improve the accuracy, precision and speed of Gleason’s scoring. These improvements, will enable better prognosis of prostate cancer and help guide the right therapies.

Read More
Cookies.

By contuining to use this website, you consent to the use of cookies in accordance with our Cookie Policy

Got It